1st Quarter - Report · 2026

Filing UUID: 74fcee91-2b2b-4894-89e8-1f259862f9e8
Type: Q1 — 1st Quarter - Report
Period: first_quarter
Year: 2026
Posted: 2026-04-20 22:21:26
Income (reported): $50,000
Expenses (reported): —
Filing document: Open on lda.senate.gov

Registrant (lobbying firm)

AVENUE SOLUTIONS

Government representation

Contact: AMY TEJRAL
Phone: +1 202-347-9848
Address: zip:20004, city:Washington, state:DC, street:401 9th St. NW Suite 720

Client

MERCK & CO. INC.

developer, manufacturer and distributor of pharmaceuticals

State: DC
Country: US
Government-entity client: false
Effective date: 2015-02-02

Issues lobbied + lobbyists

`HCR` — Health Issues

Issues related to vaccines; Public Law No: 119-75, Consolidated Appropriations Act, 2026 - issues related to expiring healthcare extenders and expiring Advanced Premium Tax Credits (APTC)

Lobbyists:

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

`MMM` — Medicare/Medicaid

Issues related to Medicare and Medicaid coverage and reimbursement; Issues related to cyclic peptides; Issues related to Most Favored Nation (MFN) drug pricing proposal; Issues related to the implementation of the Inflation Reduction Act of 2022; Issues related to Senate Finance Dear Colleague process